Reply to Roberts et al. CHEERS is Sufficient for Reporting Cost-Benefit Analysis, but May Require Further Elaboration

Don Husereau, Michael Drummond, Stavros Petrou, Dan Greenberg, Josephine Mauskopf, Federico Augustovski, Andrew H. Briggs, David Moher, Elizabeth Loder, Chris Carswell

Research output: Contribution to journalLetterpeer-review

Original languageAmerican English
Pages (from-to)535-536
Number of pages2
JournalPharmacoEconomics
Volume33
Issue number5
DOIs
StatePublished - 28 May 2015

All Science Journal Classification (ASJC) codes

  • Public Health, Environmental and Occupational Health
  • Health Policy
  • Pharmacology

Cite this